immunotherapy

Documents about immunotherapy

• Ovarian Cancer Immunology and Immunotherapy: Editorial Note#269354ODU Digital Commons
• Neoadjuvant Immunotherapy in Locally Advanced Colon Cancers#180409ClinicalTrials.gov
• Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC#148746ClinicalTrials.gov
• CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy#184831ClinicalTrials.gov
• Combination of Hyperfractionated Radiotherapy With Immunotherapy in Massive Tumors#136316ClinicalTrials.gov
• Development of a New Immunotherapy Using Intramuscular Administration of Autologous Total IgG#383558ClinicalTrials.gov
• Engineering CAR-NK Cells with Enhanced Persistence and Functionality for Cancer Immunotherapy#387914Harvard DASH
• The blockade of immune checkpoints in cancer immunotherapy#6784OpenAlex
• Retrospective Study of COVID-19 Vaccines in Patients Undergoing Immunotherapy for Cancer.#303727ClinicalTrials.gov
• CAR-T Cell Immunotherapy for HCC Targeting GPC3#123465ClinicalTrials.gov
• Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelling#154663ClinicalTrials.gov
• CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients#256882ClinicalTrials.gov
• Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer#261505ClinicalTrials.gov
• Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy#373612ClinicalTrials.gov
• Elevated ICAM5 as a promising predictor of poor prognosis in bladder cancer via EMT, immune microenvironment, and therapy resistance#269668PLOS
• Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy#160368ClinicalTrials.gov
• Nanomedicine-based cancer immunotherapy: translational barriers, mechanistic strategies, and future perspectives.#240444PubMed
• Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer#152397ClinicalTrials.gov
• Emerging Perspectives on Adverse Childhood Experiences and Brain Cancer Immunotherapy#314713Europe PMC
• Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG#390924ClinicalTrials.gov
• Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy#407738ClinicalTrials.gov
• A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.#398308ClinicalTrials.gov
• Low-moderate Intensity Pedaling During Immunotherapy Administration#152408ClinicalTrials.gov
• Advances in natural killer cell immunotherapy for hematologic malignancies#205417Europe PMC
• Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC#356481ClinicalTrials.gov
• TRAQinform Assessment of Immunotherapy Response#141015ClinicalTrials.gov
• Open Label Immunotherapy of Endometriosis#238106ClinicalTrials.gov
• Regulation of adoptive immunotherapy#385087J-STAGE (Japan)
• Opportunities and challenges for cancer immunotherapy based on antigen cross-presentation#4603Europe PMC
• The Difference of microRNA and Circulating Tumor Cells in Blood Among Cancer Patients With Immunotherapy#123452ClinicalTrials.gov
• Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients#141097ClinicalTrials.gov
• Study Evaluating Neoadjuvant Immunotherapy Increasing CD8+ Cell Infiltration in Advance Gastric Adenocarcinoma#152400ClinicalTrials.gov
• Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients#184869ClinicalTrials.gov
• Controlled Cold Exposure Combined With PD-1/PD-L1 Immunotherapy in Solid Tumors (NIVALIS)#272361ClinicalTrials.gov
• MRI DWI None-Gaussian Model Predicting Early Response to Immunotherapy in Digestive System Malignancies: a Prospective Observational Study#377409ClinicalTrials.gov
• Single-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC.#387141ClinicalTrials.gov
• Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy#178224HAL (France)
• Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC).#226240ClinicalTrials.gov
• Feasibility and Effectiveness of Liver Transplantation following Immunotherapy in Patients with Hepatocellular Carcinoma#261988HAL (France)
• Evaluation of immune microenvironment in non-small cell lung carcinoma after neoadjuvant immunotherapy. A case report#320316IRIS
• NOVEL RNA-BASED CANCER VACCINE FOR AML IMMUNOTHERAPY#330631ScholarBank@NUS
• Current topics of Cancer Immunotherapy#70149J-STAGE (Japan)
• PBMC-based Leukocyte Immunotherapy#154665ClinicalTrials.gov
• Proteome-based Personalized Immunotherapy of Glioblastoma#238104ClinicalTrials.gov
• Mapping research trends in esophageal cancer immunotherapy: A decade of thematic evolution and emerging priorities#4617Europe PMC
• Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer#174878ClinicalTrials.gov
• Neoadjuvant Radio-immunotherapy Versus Immunotherapy Alone for Locally Advanced HNSCC#184833ClinicalTrials.gov
• ompassionate access to virus-specific T cells for adoptive immunotherapy over 15 years#320839ResearchOnline@ND
• Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors#325292ClinicalTrials.gov
• Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma#245487ClinicalTrials.gov

Related topics